DXC Technology is making a big bet on artificial intelligence. The company announced a multi-year global partnership with Anthropic, the AI lab behind Claude, to embed the technology into the kind of boring-but-critical systems that banks, insurers, and governments rely on every day.
This isn't just a press release with vague promises. DXC is becoming a Global Premier partner in Anthropic's Claude Partner Network, which means it's getting early access to the latest models and tools. More importantly, DXC plans to train tens of thousands of its engineers to become Claude-certified. That's a lot of people learning how to make AI work in the real world.
DXC already uses Claude internally, but this partnership takes things further. The company is creating a dedicated group of Claude-certified engineers who will work directly inside customer environments. Think of them as AI special forces: they parachute into a bank's IT department and figure out how to make Claude handle claims processing, fraud detection, or cybersecurity alerts.
With over 115,000 employees across 70 countries, DXC has the scale to make this work. The focus on banking and insurance makes sense — those industries run on legacy systems that are ripe for AI-driven automation. If DXC can successfully embed Claude into those systems, it could be a game-changer for both companies.
The Stock Picture: A Different Story
While the AI news is exciting, DXC's stock has been anything but. Shares are trading at $8.77, down about 1.2% from their 20-day moving average of $9.19. Over the past 12 months, the stock has lost 43% of its value. Ouch.
The technical setup is mixed. The MACD indicator is above its signal line, which suggests that the selling pressure might be easing. But the stock is still facing stiff resistance at $10.00, which aligns with the 50-day moving average. On the downside, $8.00 is a key support level — that's where buyers stepped in before, and it's also near the 52-week low.
So the stock is in a bit of a no-man's land: not quite oversold enough to bounce, but not breaking out either. The AI partnership could be a catalyst, but the market seems to be taking a wait-and-see approach.
Earnings Preview: Numbers to Watch
DXC is scheduled to report its next quarterly results on July 30, 2026. Here's what analysts are expecting:
- EPS Estimate: 42 cents (down from 68 cents a year ago)
- Revenue Estimate: $2.98 billion (down from $3.16 billion)
- Valuation: P/E of 88.2x — that's a premium valuation for a company with declining earnings.
The high P/E is a red flag. It means investors are paying a lot for each dollar of earnings, which is usually justified only if growth is expected to accelerate. But with revenue and EPS both declining, that premium looks hard to defend.
Analysts are cautious. The stock carries a Hold rating with an average price target of $11.00. Recent moves from major banks tell the story:
- Morgan Stanley: Equal-Weight, lowered target to $9.00 (May 14)
- BMO Capital: Market Perform, lowered target to $10.00 (May 11)
- TD Cowen: Hold, lowered target to $14.00 (April 6)
Notice a pattern? All three lowered their targets recently. That's not a vote of confidence.
How DXC Ranks on Key Metrics
MarketDash's Edge scorecard gives DXC a mixed report card:
- Value: 93.14 — The stock looks cheap compared to peers.
- Growth: 32.58 — Moderate growth potential.
- Quality: 7.18 — Weak performance indicators.
- Momentum: 3.46 — The stock is underperforming the broader market.
The verdict: DXC is a value trap in the making. It's cheap for a reason — weak quality and terrible momentum. The AI partnership could improve the growth and quality scores over time, but that's a long-term story, not a near-term catalyst.
ETF Exposure: Who Owns DXC?
If you're looking for indirect exposure, two ETFs hold notable positions in DXC:
- Pacer US Small Cap Cash Cows 100 ETF (CALF): 2.07% weight.
- Harbor Long-Short Equity ETF (LSEQ): 2.64% weight.
Because DXC carries meaningful weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock. So keep an eye on those fund flows if you're trading DXC.
The Bottom Line
DXC's partnership with Anthropic is a smart strategic move. AI is going to reshape enterprise IT, and DXC is positioning itself as a key player. But the stock's technical and fundamental picture is messy. The high P/E, declining earnings, and weak momentum suggest that the market is pricing in a lot of risk.
If the AI partnership leads to real revenue growth, the stock could be a bargain. But for now, it's a show-me story. The next earnings report on July 30 will be a critical test.
Photo via Shutterstock
